A detailed history of Mackenzie Financial Corp transactions in Insmed Inc stock. As of the latest transaction made, Mackenzie Financial Corp holds 9,670 shares of INSM stock, worth $682,605. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,670
Previous 8,533 13.32%
Holding current value
$682,605
Previous $571,000 23.47%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$62.0 - $79.01 $70,494 - $89,834
1,137 Added 13.32%
9,670 $705,000
Q3 2023

Oct 25, 2023

BUY
$19.86 - $26.93 $169,465 - $229,793
8,533 New
8,533 $215,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.56B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.